XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |
BRAIDWELL LP | 2,103,396 | $71,852,007 | 2.27% |
Nicholas Investment Partners, LP | 854,447 | $29,187,910 | 2.18% |
Logos Global Management LP | 450,000 | $15,372,000 | 2.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,513,005 | $154,164,251 | 2.00% |
First Light Asset Management, LLC | 602,070 | $20,566,711 | 1.95% |
Tri Locum Partners LP | 171,755 | $5,867,151 | 1.88% |
BVF INC/IL | 1,827,958 | $62,443,045 | 1.68% |
Connacht Asset Management LP | 8,204 | $280,249 | 1.66% |
Parkman Healthcare Partners LLC | 216,644 | $7,400,559 | 1.36% |
Ghost Tree Capital, LLC | 98,951 | $3,380,166 | 1.11% |
External links
This page lists XENON PHARMACEUTICALS INC's shareholders in Q3 2023. To view XENON PHARMACEUTICALS INC's shareholder history, click here.